Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer Faruk TasDerya DuranyildizErkan Topuz Original Article 07 June 2007 Pages: 721 - 725
Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells Markus DuechlerMałgorzata StańczykMaciej Stępnik Original Article 27 June 2007 Pages: 727 - 737
The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity Lonnie P. SwiftSuzanne M. CuttsDon R. Phillips Original Article 27 June 2007 Pages: 739 - 749
Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors Toshio ShimizuNoboru YamamotoTomohide Tamura Original Article 27 June 2007 Pages: 751 - 758
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) Amanda F. CashenAjit K. ShahJohn DiPersio Original Article 13 June 2007 Pages: 759 - 766
Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells María S. MolinuevoAna M. CortizoSusana B. Etcheverry Original Article 19 June 2007 Pages: 767 - 773
Role of cytokines (TNF-α, IL-1β and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide Maria Luisa P. MeloGerly A. C. BritoRonaldo A. Ribeiro Original Article 12 July 2007 Pages: 775 - 784
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas Frank P. KroschinskyKai FriedrichsenEberhard Schleyer Original Article 20 June 2007 Pages: 785 - 790
Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid Aiping TongHaiyuan ZhangYuquan Wei Original Article 26 June 2007 Pages: 791 - 802
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study F. V. PiantedosiF. CaputoA. Bianco Original Article 18 July 2007 Pages: 803 - 807
Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice Daniele MartarelliPierluigi PompeiGiovanni Mazzoni Original Article 21 June 2007 Pages: 809 - 817
Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed Sang Hee MinI. David GoldmanRongbao Zhao Original Article 27 June 2007 Pages: 819 - 827
Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer Kentaro OkudaTakashi HiroseMitsuru Adachi Original Article 23 June 2007 Pages: 829 - 835
Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer Jae-Lyun LeeHye Jin KangJung Shin Lee Original Article 20 June 2007 Pages: 837 - 845
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline Ruey-Long HongChing-Hung LinWei-Shou Hwang Original Article 04 July 2007 Pages: 847 - 853
Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma Delphine RollandValérie Camara-ClayetteCatherine Thieblemont Original Article 18 July 2007 Pages: 855 - 863
Plasma pharmacokinetic evaluation of cytotoxic agents radiolabelled with positron emitting radioisotopes A. SaleemE. O. AboagyeP. M. Price Original Article 18 July 2007 Pages: 865 - 873
Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer Izuru WatanabeHideki KasuyaAkimasa Nakao Original Article 29 August 2007 Pages: 875 - 882
Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro Daisuke KawasakiYutaka EmoriSusan A. Watson Original Article 28 September 2007 Pages: 883 - 892
Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed Camilla PalumboSonia BattistiAndrea Modesti Original Article 06 October 2007 Pages: 893 - 901
